Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
December 2026 407
2026-12-31
Study completion Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06055452
2026-12-31
Primary completion Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06055452
2026-12-31
Primary completion Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06108414
2026-12-31
Study completion Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06148285
2026-12-31
Primary completion Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06148285
2026-12-31
Study completion SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06155604
2026-12-31
Primary completion SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06155604
2026-12-31
Study completion Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06164808
2026-12-31
Primary completion Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06164808
2026-12-31
Primary completion VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06249165
2026-12-31
2026-12-31
2026-12-31
Study completion Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06264427
2026-12-31
Study completion Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06297863
2026-12-31
2026-12-31
2026-12-31
2026-12-31
Primary completion Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06399835
2026-12-31
Primary completion Clopidogrel Versus Cilostazol on Vessels Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06402747
2026-12-31
Study completion The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06416644
2026-12-31
Primary completion The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06416644
2026-12-31
2026-12-31
Study completion Reducing Salt and Sugar in Campus Foods: A Malaysian Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06473038
2026-12-31
Primary completion Reducing Salt and Sugar in Campus Foods: A Malaysian Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06473038
2026-12-31
Primary completion Priming Theta Burst Stimulation for Stroke: A Study of Intensity Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06509789
2026-12-31
Primary completion Using Remote Monitoring to Address Health Disparities in Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06517576
2026-12-31
2026-12-31
2026-12-31
2026-12-31
Study completion Endocardial Mapping With the CoreMap EP Mapping System Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06529978
2026-12-31
Primary completion Endocardial Mapping With the CoreMap EP Mapping System Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06529978
2026-12-31
2026-12-31
2026-12-31
Study completion A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06539689
2026-12-31
2026-12-31
2026-12-31
Study completion Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06578234
2026-12-31
Primary completion Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06578234
2026-12-31
Study completion Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06643819
2026-12-31
2026-12-31
2026-12-31
2026-12-31
Study completion Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06669169
2026-12-31
Primary completion Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06669169
2026-12-31
2026-12-31
2026-12-31
2026-12-31
Study completion Impact of Catheter Stability on the Outcomes With Very High Power Short Duration Ablation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06721221
2026-12-31
Primary completion Impact of Catheter Stability on the Outcomes With Very High Power Short Duration Ablation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06721221
2026-12-31
Study completion Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06736899
2026-12-31
Primary completion Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06736899
2026-12-31
Primary completion Intravenous Thrombolysis and NOAC Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06749834
2026-12-31
Study completion Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06762223
2026-12-31
Primary completion Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06762223
2026-12-31
Primary completion TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06802081
2026-12-31
Study completion Motor-Cognitive Interactive Upper Limb Robot Rehabilitation for Post-Stroke Motor Dysfunction Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06876597
2026-12-31
Primary completion Motor-Cognitive Interactive Upper Limb Robot Rehabilitation for Post-Stroke Motor Dysfunction Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06876597
2026-12-31
Study completion Robot-Assisted Tai Chi for Upper Limb Rehabilitation in Stroke Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06897631
2026-12-31
Primary completion Robot-Assisted Tai Chi for Upper Limb Rehabilitation in Stroke Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06897631
2026-12-31
Study completion SONICURE(SONICracker for the Treatment of UndeRExpansion) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06924736
2026-12-31
2026-12-31
2026-12-31
Study completion Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06946732
2026-12-31
Study completion Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06959784
2026-12-31
Primary completion Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06959784
2026-12-31
2026-12-31
Primary completion Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06989723
2026-12-31
2026-12-31
Study completion BM Shockwave Devices Clinical Study in Coronary Calcified Lesions Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07010094
2026-12-31
Study completion Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07018557
2026-12-31
Study completion Nefecon and Ambrisentan in IgA Nephropathy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07030894
2026-12-31
Primary completion Nefecon and Ambrisentan in IgA Nephropathy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07030894
2026-12-31
Primary completion Trial of Mobile External Defibrillator for Out-of-hospital Cardiac Arrest in Singapore. Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07042061
2026-12-31
Primary completion Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07067658
2026-12-31
2026-12-31
Study completion A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07091994
2026-12-31
Primary completion A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07091994
2026-12-31
2026-12-31
2026-12-31
Study completion Connected Care for Type 2 Diabetes Self-Management Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07149610
2026-12-31
Study completion ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07187713
2026-12-31
Study completion Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07225101
2026-12-31
Primary completion Comparison of the Amplatzer Amulet Versus LAmbre Device for Left Atrial Appendage Closure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07260474
2026-12-31
Study completion Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07290751
2026-12-31
Primary completion Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07311343
2026-12-31
Primary completion Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07336329
2026-12-31
Study completion Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke. Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07396337
2026-12-31
Study completion Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07397351
2026-12-31
Primary completion CART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07465549
2026-12-31
2026-12-31
2026-12-31
Study completion Digital Application for Stroke Health Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07511868
2026-12-31
Primary completion Digital Application for Stroke Health Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07511868
2026-12-31
Study completion Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07536802
2026-12-31
2026-12-31
2026-12-31
Primary completion Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07617376
2026-12-31
Primary completion Effects of CTAR and a Swallowing Pressure Ball in Older Stroke Adults Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07620210
2026-12-31
2026-12-31
Primary completion A Randomized Trial of Carotid Artery Stenting With Balloon Guide Catheter Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07678164
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2015-09
Primary completion CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial) Registry record
Expected 2015-09; that period ended on 2015-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01877746
2015-09
Study completion Phase II Randomized Placebo-controlled Study With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis Registry record
Expected 2015-09; that period ended on 2015-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01923012
2015-09
Primary completion Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events Registry record
Expected 2015-09; that period ended on 2015-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01923818
2015-09
2015-09
Study completion Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy Registry record
Expected 2015-09; that period ended on 2015-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02129985
2015-09
Primary completion Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self Care Registry record
Expected 2015-09; that period ended on 2015-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02225691
2015-09
Study completion Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure Registry record
Expected 2015-09; that period ended on 2015-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02357615
2015-09
Study completion Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol Registry record
Expected 2015-09; that period ended on 2015-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02403349
2015-10
Study completion The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome Registry record
Expected 2015-10; that period ended on 2015-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01068093
2015-10
Primary completion The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome Registry record
Expected 2015-10; that period ended on 2015-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01068093
2015-10
Study completion Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study Registry record
Expected 2015-10; that period ended on 2015-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01462188
2015-10
Study completion Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus Registry record
Expected 2015-10; that period ended on 2015-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01954147
2015-10
2015-10
Primary completion Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome Registry record
Expected 2015-10; that period ended on 2015-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02049229
2015-10
Primary completion Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients Registry record
Expected 2015-10; that period ended on 2015-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02254824
2015-10
Study completion Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina Registry record
Expected 2015-10; that period ended on 2015-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02280850
2015-10
Primary completion Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran Registry record
Expected 2015-10; that period ended on 2015-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02331602
2015-10
Primary completion Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension Registry record
Expected 2015-10; that period ended on 2015-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02407210
2015-11
Study completion Surgical Treatment of Ischemic Mitral Regurgitation Registry record
Expected 2015-11; that period ended on 2015-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01368575
2015-11
Primary completion The Mobile Diabetes Mgmt. Study With Type 2 Diabetes Registry record
Expected 2015-11; that period ended on 2015-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02451631
2015-12
Study completion Anticoagulation in Stent Intervention Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01141153
2015-12
Primary completion Anticoagulation in Stent Intervention Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01141153
2015-12
Primary completion Comparative Study of GangTrainer GT1, Lokomat and Conventional Physiotherapy Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01146587
2015-12
Study completion Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01162902
2015-12
Study completion Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01175486
2015-12
Study completion The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01270191
2015-12
Study completion The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01278498
2015-12
Study completion Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01305148
2015-12
Primary completion Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01305148
2015-12
Study completion Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01341353
2015-12
Study completion Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01433627
2015-12
Study completion Customized Choice of Oral P2Y12 Receptor Blocker Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01477775
2015-12
Primary completion Effects of DES Platforms on Markers of Endothelial Damage and Inflammation Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01489202
2015-12
Primary completion Ranolazine Loading to Prevent PCI-induced Myocardial Injury Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01491061
2015-12
Primary completion N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01491243
2015-12
Primary completion PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01648829
2015-12
Primary completion Nutraceuticals to Improve Lipid Profile in European Countries Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01649986
2015-12
Primary completion Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01658410
2015-12
Study completion Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01670318
2015-12
Primary completion Single Long vs Two Short Overlapping Bioabsorbable Polymer DES Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01718106
2015-12
Study completion Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01790308
2015-12
Primary completion Cholesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant Patients Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01807078
2015-12
Primary completion Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01810224
2015-12
Primary completion Efficacy and Safety Study of Ticagrelor Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01812330
2015-12
Study completion Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01862978
2015-12
Primary completion Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01869309
2015-12
Study completion A Trial to Evaluate Efficacy of Heart-protecting Musk Pill Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01897805
2015-12
Primary completion Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01918150
2015-12
Primary completion Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01924325
2015-12
Study completion Bedside Sleep Medicine Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01924507
2015-12
Study completion PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01930903
2015-12
Primary completion PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01930903
2015-12
Primary completion Comparison of the Quality of CPR by Lay Rescuers With and Without Feedback Devices Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02000505
2015-12
Study completion Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02001883
2015-12
Study completion Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02002923
2015-12
Primary completion Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02005302
2015-12
Primary completion Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02008448
2015-12
Primary completion Renal Denervation in Heart Failure Patients With Preserved Ejection Fraction (RESPECT-HF) Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02041130
2015-12
Study completion A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02059616
2015-12
Primary completion LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02077257
2015-12
Study completion A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02152280
2015-12
Primary completion A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02152280
2015-12
Primary completion the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery. Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02158559
2015-12
Primary completion Surgical Ablation of Long-standing Persistent AF During CABG Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02246790
2015-12
Primary completion Drug Eluting Balloon in peripherAl inTErvention for Below-The-Knee Arteries With Freeway and Lutonix Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02279784
2015-12
Study completion Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02314663
2015-12
Primary completion Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02314663
2015-12
Study completion Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02331602
2015-12
Primary completion Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02343393
2015-12
Study completion A Study of tDCS for Swallowing Difficulties in Stroke Patients Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02422225
2015-12
Primary completion A Study of tDCS for Swallowing Difficulties in Stroke Patients Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02422225
2015-12
Primary completion Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02426294
2015-12
Primary completion The Pacing vs No Pacing Study - PNP Study Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02498639
2015-12
Study completion Health Education Using Text Messaging Prevents Hypertension in High Risk People Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02551926
2015-12
Primary completion Health Education Using Text Messaging Prevents Hypertension in High Risk People Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02551926
2015-12
Primary completion HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure Registry record
Expected 2015-12; that period ended on 2015-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02608632
2016-01
Primary completion Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy Registry record
Expected 2016-01; that period ended on 2016-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01823185
2016-01
Study completion Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation Registry record
Expected 2016-01; that period ended on 2016-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02008448
2016-01
Primary completion Treatment of Hypertension in Tibetan Adult Population Registry record
Expected 2016-01; that period ended on 2016-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02217852
2016-01
Study completion Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Registry record
Expected 2016-01; that period ended on 2016-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02334254
2016-01
Primary completion Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Registry record
Expected 2016-01; that period ended on 2016-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02334254
2016-01
Study completion The Pacing vs No Pacing Study - PNP Study Registry record
Expected 2016-01; that period ended on 2016-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02498639
2016-01
Primary completion Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD Registry record
Expected 2016-01; that period ended on 2016-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02551172
2016-02
Study completion Comparative Study of GangTrainer GT1, Lokomat and Conventional Physiotherapy Registry record
Expected 2016-02; that period ended on 2016-02-29.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01146587
2016-02
Study completion The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris Registry record
Expected 2016-02; that period ended on 2016-02-29.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01325818
2016-02
Study completion Comparison of the Quality of CPR by Lay Rescuers With and Without Feedback Devices Registry record
Expected 2016-02; that period ended on 2016-02-29.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02000505
2016-02
Study completion A Study of tDCS for Unilateral Neglect in Stroke Patients Registry record
Expected 2016-02; that period ended on 2016-02-29.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02506075
2016-02
Primary completion A Study of tDCS for Unilateral Neglect in Stroke Patients Registry record
Expected 2016-02; that period ended on 2016-02-29.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02506075
2016-02
Study completion Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD Registry record
Expected 2016-02; that period ended on 2016-02-29.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02551172
2016-02
Study completion HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure Registry record
Expected 2016-02; that period ended on 2016-02-29.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02608632
2016-03
Primary completion Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2 Registry record
Expected 2016-03; that period ended on 2016-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01561222
2016-03
Study completion Single Long vs Two Short Overlapping Bioabsorbable Polymer DES Registry record
Expected 2016-03; that period ended on 2016-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01718106
2016-03
Study completion Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy Registry record
Expected 2016-03; that period ended on 2016-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01823185
2016-03
Primary completion Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy Registry record
Expected 2016-03; that period ended on 2016-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01893788
2016-03
Study completion Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII Registry record
Expected 2016-03; that period ended on 2016-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01918150
2016-03
Primary completion Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin Registry record
Expected 2016-03; that period ended on 2016-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02029014
2016-03
Primary completion Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension Registry record
Expected 2016-03; that period ended on 2016-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02029885
2016-03
Study completion Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self Care Registry record
Expected 2016-03; that period ended on 2016-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02225691
2016-03
Study completion Comparison of Primary PCI vs. Post-thrombolysis PCI as Reperfusion Strategies in STEMI Registry record
Expected 2016-03; that period ended on 2016-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02268669
2016-03
Study completion The Mobile Diabetes Mgmt. Study With Type 2 Diabetes Registry record
Expected 2016-03; that period ended on 2016-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02451631